TCL Archive Oxaliplatin Regimens Extend Survival Of Advanced Colorectal Cancer, Study Finds June 27, 2003
TCL Archive Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin July 23, 2010
TCL Archive In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays April 9, 1976
TCL Archive In Brief: Fleming New ACCC President, Jennifer Guy President Elect; Rauscher Joins UNIMED Board April 7, 1989
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004